Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
| NCT ID | NCT02379390 |
| Title | Cabazitaxel Versus the Switch to Alternative AR Targeted Therapy Enzalutamide or Abiraterone in Metastatic Castration-Resistant Prostate Cancer (mCRPC) Primary Resistant Patients to Abiraterone or Enz (PRIMCAB) |
| Acronym | PRIMCAB |
| Recruitment | Terminated |
| Gender | male |
| Phase | Phase II |
| Variant Requirements | No |
| Sponsors | Sanofi |
| Indications | |
| Therapies | |
| Age Groups: | adult |
| Covered Countries | USA | CAN |